Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

Fig. 2

The relationship between CTCs/CTM and clinicopathological characteristics in advanced CRC. a Serum CEA levels in CTC-positive patients were higher than CTC-negative patients (P = 0.0155). b There was no statistical significance in serum CA199 levels between CTC-positive and CTC-negative patients (P = 0.0887). c The correlation of CTC count with tumor de-differentiation (poor vs. middle, P = 0.0191; poor vs. high, P = 0.0359). d CTC count of patients with depth of invasion (T4a vs. T4b, P = 0.7826; T4a vs. T3, P = 0.3708; T4a vs. T1 + T2, P = 0.4762). e The correlation of CTC count with lymphatic invasion (N2b vs. N0, P = 0.0429; N2b vs. N1, P = 0.0361; N2b vs. N2a, P = 0.1037). f The correlation of CTC count with TNM stage (IVb vs. III, P = 0.0186; IVb vs. IVa, P = 0.1019). g CTC count of patients with CEA > 10 pg/ml was more than CEA ≤ 10 pg/ml (P = 0.0026)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us